Polymeric nanoparticle-mediated in situ co-delivery of RNAi and chemotherapy drugs for cancer immunotherapy
Time: 4:00 pm
day: Conference Day Two
Details:
- Introducing a polymeric nanoparticle system that is highly effective in tumor targeting through effective tumor EC-mediated active targeting while minimizing LSEC-mediated liver uptake
- Outlining the effectiveness of controlling tumor growth using this dual treatment strategy that can simultaneously co-deliver chemotherapy drugs with novel immunotherapies
- Spotlighting the translational effect of targeting Xkr8 in combination with chemotherapy for the treatment of various types of cancers in clinic
